Inventor

PRESS JEFFERY B

US41 patents

⚠️ This page may combine multiple inventors who share the name “PRESS JEFFERY B”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

PRESS JEFFERY B

ORTHO PHARMA CORP

2- Or 3- aryl substituted imidazo [1,2-a]pyridines

4-phenyl tetrahydropyrido(4,3-d)pyrimidines

Substituted imidazole and pyridine derivatives

Phenyl and benzoyl substituted imidazo-fused heterocyclic calcium channel blockers

6-Substituted purinyl piperazine derivatives useful as cardiotonic and antiarrhythmic agents

2-Aryloxyalkylaminobenzoxazoles and 2-aryloxyalkylaminobenzothiazoles

Thieno- and furopyrimidine-2,4-dione piperidine derivatives as serotonin antagonists and alpha adrenergic blocking agents

Isoquinolinol compounds having cardiotonic and phosphodiesterase fraction III inhibiting properties and/or renal vasodilating properties

Furo(3,4-d)pyrimidine-2,4-dione derivatives and intermediates thereof

Thienopyrimidine-2,4-dione derivatives and intermediates thereof

2- or 3-aryl substituted imidazo[1,2-a]pyridines and their use as calcium channel blockers

2-substituted-4-aryl-substituted thiazoles

4-Substituted pyrazolo[3,4-D]pyrimidine derivatives

2- or 3-aryl substituted imidazo(1,2-A)pyridines and their use as antisecretory agents

Thienopyridines useful as cardiovascular agents

Substituted thienopyrans as antihypertensive agents

6-substituted purinyl piperazine derivatives

N-(substituted thienyl)-N&#39;-(substituted piperazinyl)-ureas

Substituted thienopyrans as antihypertensive agents

Substituted biphenylalkoxyamines

Substituted thienopyrans

6-substituted purinyl piperazine derivatives

Substituted thienopyrans as antihypertensive agents

O-functionalized derivatives of substituted isoquinolin-3-ols having cardiotonic and/or phosphodiesterase fraction III inhibiting properties and/or renal vasodilating properties

4-nitrogen substituted isoquinolinol compounds having cardiotonic, phosphodiesterase fraction III inhibiting properties and/or renal vasodilating properties

4-substituted pyrazolo[3,4-d]pyrimidine derivatives

Process for preparing 5,6-dialkoxy-4-alkyl-2(1H)-quinazolinones

4-substituted pyrazolo[3,4-d]pyrimidine derivatives

Process for the preparation of enantiomerically pure thienopyran derivatives

6-substituted purinyl piperazine derivatives

Process for preparing 5,6-dialkoxy-4-alkyl-2(1H)-quinazolinones

AMERICAN CYANAMID CO

N-(Substituted phenyl)-N&#39;-[(1H-imidazol-1-yl) and (1H-1,2,4-triazol-1-yl)alkyl]ureas

N-[(1H-imidazol-1-yl)alkyl]-1H-indolecarboxamides useful as thromboxane synthetase inhibitors and antihypertensive agents

N-[(1H-1,2,4-Triazol-1-yl)alkyl]-arylamides

Substituted N-[(1H-1,2,4-triazol-1-yl)-alkyl]heteroarylcarboxamides

10-(Piperazinyl)thieno[3,4-b][1,5]benzoxazepines and 10-(piperazinyl)thieno[3,4-b][1,5]benzothiazepines

Thromboxane synthetase enzyme inhibiting N-[(1H-imidazol-1-yl) and (1H-1,2,4-triazol-1-yl)alkyl]pyridinecarboxamides

Thieno[3,4-b][1,5]benzoxazepin-10-ones and thieno[3,4-b][1,5]benzothiazepin-10-ones

Novel 4-(substituted-aminophenoxy)-3-thiophenemethanols

4H-Thieno[3,4-b][1,4]benzodiazepines

GALENICA PHARMACEUTICALS INC

Chemically modified saponins and the use thereof as adjuvants

N-(substituted thienyl)-N'-(substituted piperazinyl)-ureas

N-(Substituted phenyl)-N'-[(1H-imidazol-1-yl) and (1H-1,2,4-triazol-1-yl)alkyl]ureas